Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0W9PG
|
||||
Former ID |
DIB016590
|
||||
Drug Name |
Pyrazinoylguanidine
|
||||
Synonyms |
PZG
|
||||
Indication | Diabetes [ICD9: 253.5, 588.1; ICD10:E23.2, N25.1] | Discontinued in Phase 2 | [545139] | ||
Company |
Sparta Pharmaceuticals Inc
|
||||
Structure |
Download2D MOL |
||||
Canonical SMILES |
N(C(=O)c1nccnc1)C(=N)N
|
||||
CAS Number |
CAS 60398-24-5
|
||||
Target and Pathway | |||||
Target(s) | Sodium channel | Target Info | Modulator | [528291] | |
KEGG Pathway | Dopaminergic synapse | ||||
Reactome | Interaction between L1 and Ankyrins | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.